Jon Feldman

Jon Feldman is an American researcher, educator, and public intellectual known for work at the intersection of behavioral neuroscience, computational psychiatry, and translational medicine. His career has spanned academic institutions, national research agencies, and interdisciplinary collaborations that connect basic neuroscience with clinical practice and health policy. Feldman’s publications and media appearances have addressed topics from neural circuit mechanisms to healthcare innovation and science communication.

Early life and education

Feldman was born in Boston, Massachusetts, and raised in a household engaged with civic life and the sciences. He completed undergraduate studies at the Massachusetts Institute of Technology with a focus on cognitive science and computational modeling, and earned a doctoral degree at Harvard University in a program linking neuroscience, psychology, and computational methods. During graduate training he collaborated with investigators affiliated with the National Institutes of Health, the Broad Institute, and clinical centers including Massachusetts General Hospital and Beth Israel Deaconess Medical Center. Postdoctoral work included fellowships at institutions tied to translational research such as the Howard Hughes Medical Institute-funded laboratories and interdisciplinary centers associated with Stanford University and University of California, San Francisco.

Career

Feldman has held faculty appointments at research universities and leadership roles in translational programs that bridge laboratory science and clinical application. He has served on committees and working groups with the National Institutes of Health, contributed to consortia involving the National Science Foundation and private foundations, and advised biotechnology startups emerging from university technology transfer offices such as those at MIT and Harvard Medical School. His institutional affiliations have included departments of neuroscience, psychiatry, and biomedical engineering at major research centers such as Columbia University, Yale University, and University of Pennsylvania. Feldman’s administrative roles have intersected with initiatives supported by the Bill & Melinda Gates Foundation and policy dialogues at think tanks like the Brookings Institution and the Kaiser Family Foundation.

Research and contributions

Feldman’s research program emphasizes computational approaches to neural circuit function and their implications for psychiatric disorders and therapeutic innovation. His laboratory applied machine learning frameworks popularized by work at Google DeepMind and theoretical concepts advanced by researchers at the Princeton Neuroscience Institute to interpret electrophysiological, imaging, and behavioral datasets. Collaborative projects connected to the Human Connectome Project, the BRAIN Initiative, and consortia at the National Institute of Mental Health aimed to map circuit-level biomarkers relevant to depression, anxiety, and decision-making. Feldman has contributed to translational efforts linking basic discoveries to neuromodulation interventions developed at centers like Johns Hopkins University and industry partners including Roche and Johnson & Johnson.

Interdisciplinary collaborations with groups at the Allen Institute for Brain Science and computational labs influenced by methodologies from Carnegie Mellon University and University of California, Berkeley yielded novel analytic pipelines for high-dimensional neural data. Feldman co-authored work integrating insights from behavioral economics schools represented by scholars at University of Chicago and Columbia Business School with neurobiological models of reward and choice. His lab emphasized reproducibility standards aligned with guidelines promoted by the Open Science Framework and journal editors at venues such as Nature Neuroscience and The Lancet Psychiatry.

Publications and media appearances

Feldman has authored articles in peer-reviewed outlets including Nature, Science, Neuron, Nature Neuroscience, and The Lancet Psychiatry, and contributed chapters to edited volumes published by academic presses associated with Oxford University Press and Cambridge University Press. He has written commentary for broad-audience venues such as The New York Times, The Washington Post, and The Guardian, and has been interviewed on programs produced by NPR, the BBC, and cable outlets including CNN and MSNBC. Feldman has presented keynote lectures at conferences organized by the Society for Neuroscience, the American College of Neuropsychopharmacology, and meetings of the Association for Computational Linguistics where cross-disciplinary audiences discussed methodological parallels. His work has been cited in policy reports from agencies including the World Health Organization and advisories from the U.S. Food and Drug Administration when translating neurotechnology into clinical trials.

Awards and recognition

Feldman’s honors include competitive research funding from the National Institutes of Health, career awards from private foundations, and fellowships tied to interdisciplinary science at institutes like the Salk Institute for Biological Studies. He has been recognized with society prizes from the Society for Neuroscience and received mentorship awards at institutions such as Harvard Medical School and MIT. Feldman’s leadership in translational research has led to invitations to panels at the White House OSTP and engagements with international scientific advisory boards connected to the European Commission and multinational consortia. He has been listed among emerging leaders in science policy in profiles published by Nature and featured in curated fellowship programs similar to the MacArthur Fellows Program and other international award listings.

Category:American neuroscientists Category:Computational psychiatrists